Pancreatic cancer drug Daraxonrasib gets approval from FDA: All you need to know
FDA officials gave expedited approval to daraxonrasib, which blocks a mutated protein that fuels tumor growth
Real-time cancer treatment news, structured for developers. NewsMesh surfaces cancer treatment coverage from outlets across 35 countries and serves it as clean JSON, each story tagged with its category, the countries it's relevant to, and the named people detected in the body. Pull it with full-text search (GET /v1/search?q=) and layer category, country, or date filters on top, no scraping required.
FDA officials gave expedited approval to daraxonrasib, which blocks a mutated protein that fuels tumor growth
“More and more, there's new targeted therapies that are emerging all the time."
The US FDA on Wednesday approved Revolution Medicines' Rasonque for advanced pancreatic cancer, opening a new treatment option for patients with metastatic disease. A large tria...
The FDA approves a new therapy against one of the deadliest cancers.
The therapy is a brand new targeted drug for the disease which experts have labelled as a substantial breakthrough following doubling of survival time in a trial.
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy. The post FDA approves drug poised to transform care for panc...
The drug, Rasonque, nearly doubled median overall survival compared with standard chemotherapy in a 500-patient trial
The Food and Drug Administration on Wednesday approved a groundbreaking pancreatic cancer drug that experts predict will transform treatment for the notoriously deadly disease.
Engineered immune cells that normally calm inflammation reduced allergic airway reactions in mice, suggesting that a technology developed for cancer could eventually be used to ...
TLDR The FDA approved Revolution Medicines’ drug Rasonque (daraxonrasib) for metastatic pancreatic adenocarcinoma on August 26, 2026 The approval came months ahead of schedule, ...
<p>WASHINGTON (AP) — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for the most common form of pancreatic cancer, offering U.S. patients a mor...
Pancreatic cancer is considered one of the hardest to treat and most serious cancers
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
Daraxonrasib is being hailed as a potential game changer for metastatic pancreatic cancer, roughly doubling survival vs chemotherapy in previously treated patients. Medscape Med...
Busy Philipps says she had to go under the knife twice to remove a rare brain tumor ... a shocking health crisis she's revealing for the first time. The actress was diagnosed in...
The FDA has approved new first-line treatment options for adults with certain HER2-positive gastric, gastroesophageal junction and esophageal cancers. The agency approved Ziiher...
Cancer has emerged as an unavoidable issue on the campaign trail in Iowa, where candidates vying for two of the state’s most powerful offices are offering competing prescription...
The 83-year-old singer has recently been treated for cancer.
NewsMesh surfaces cancer treatment coverage from sources across 35 countries, normalised into one structured feed you can query by keyword, category, country, and date.
Authenticate with your apiKey and call one endpoint (GET api.newsmesh.co/v1/search?q=cancer+treatment). The examples below are ready to copy.
curl "https://api.newsmesh.co/v1/search?apiKey=nm_xxx&q=cancer+treatment&limit=20"GET /v1/latest: Most-recent articles, filterable by category, country, and date range.GET /v1/search: Full-text search across the archive with boolean operators and source filters.GET /v1/trending: Cached trending headlines, the fastest endpoint for homepage feeds.GET /v1/article/{id}: Fetch a single article and its full metadata by ID.Call GET /v1/search?q=cancer treatment with your apiKey to return recent cancer treatment stories as structured JSON. Add &category= or &country= to narrow the results.
Every cancer treatment article carries its category, the countries it's relevant to, and the named people detected in the body, so you can route and filter without your own NLP layer.
Yes. Add &category=technology (or business, politics, and more) and &country=us (or any ISO country code) to the search query to focus the feed.
Yes. NewsMesh is a real-time news API: cancer treatment stories are served through the live /v1/latest and /v1/trending endpoints alongside a searchable archive, each tagged with its category, the countries it's relevant to, and the named people detected in the body, so you can build a live feed without scraping HTML.
Create a NewsMesh account, generate an API key, and call the endpoint above with your apiKey parameter. See the pricing page for current plans and rate limits.
Access the full dataset programmatically with the NewsMesh API.